Design, synthesis, and evaluation of a novel series of macrocyclic inhibitors of norovirus 3CL protease

被引：10

作者：

Damalanka, Vishnu C. ^{[1
]}

Kim, Yunjeong ^{[2
]}

Kankanamalage, Anushka C. Galasiti ^{[1
]}

Lushington, Gerald H. ^{[3
]}

Mehzabeen, Nurjahan ^{[4
]}

Battaile, Kevin P. ^{[5
]}

Lovell, Scott ^{[4
]}

Chang, Kyeong-Ok ^{[2
]}

Groutas, William C. ^{[1
]}

机构：

[1] Wichita State Univ, Dept Chem, Wichita, KS 67260 USA

[2] Kansas State Univ, Dept Diagnost Med & Pathobiol, Coll Vet Med, Manhattan, KS 66506 USA

[3] LiS Consulting, Lawrence, KS 66046 USA

[4] Univ Kansas, Prot Struct Lab, Lawrence, KS 66047 USA

[5] APS Argonne Natl Lab, Hauptman Woodward Med Res Inst, IMCA CAT, Argonne, IL 60439 USA

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2017年 / 127卷

基金：

美国国家卫生研究院;

关键词：

Macrocyclic inhibitors; Norovirus; 3CLprotease; SUBSTRATE-SPECIFICITY; CELL-PERMEABILITY; GASTROENTERITIS; RULE; OPTIMIZATION; CANDIDATES; DISCOVERY; FOODBORNE; CYSTEINE; TARGETS;

D O I：

10.1016/j.ejmech.2016.12.033

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Norovirus infections have a major impact on public health worldwide, yet there is a current dearth of norovirus-specific therapeutics and prophylactics. This report describes the discovery of a novel class of macrocyclic inhibitors of norovirus 3C-like protease, a cysteine protease that is essential for virus replication. SAR, structural, and biochemical studies were carried out to ascertain the effect of structure on pharmacological activity and permeability. Insights gained from these studies have laid a solid foundation for capitalizing on the therapeutic potential of the series of inhibitors described herein. (C) 2016 Elsevier Masson SAS. All rights reserved.

引用

页码：41 / 61

页数：21

共 50 条

[1] Design, Synthesis, and Evaluation of Novel Prodrugs of Transition State Inhibitors of Norovirus 3CL Protease
Kankanamalage, Anushka C. Galasiti
Kim, Yunjeong
Rathnayake, Athri D.
Alliston, Kevin R.
Butler, Michelle M.
Cardinale, Steven C.
Bowlin, Terry L.
Groutas, William C.
Chang, Kyeong-Ok
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (14) : 6239 - 6248
[2] Putative structural rearrangements associated with the interaction of macrocyclic inhibitors with norovirus 3CL protease
Kankanamalage, Anushka C. Galasiti
Weerawarna, Pathum M.
Rathnayake, Athri D.
Kim, Yunjeong
Mehzabeen, Nurjahan
Battaile, Kevin P.
Lovell, Scott
Chang, Kyeong-Ok
Groutas, William C.
[J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2019, 87 (07) : 579 - 587
[3] Novel prodrugs of transition state inhibitors of norovirus 3CL protease
Kankanamalage, Anushka Galasiti
Kim, Yunjeong
Alliston, Kevin
Rathnayake, Athri
Butler, Michelle
Cardinale, Setven
Bowlin, Terry
Chang, Kyeong-Ok
Groutas, William
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
[4] Structure-guided design, synthesis and evaluation of oxazolidinone-based inhibitors of norovirus 3CL protease
Damalanka, Vishnu C.
Kim, Yunjeong
Kankanamalage, Anushka C. Galasiti
Rathnayake, Athri D.
Mehzabeen, Nurjahan
Battaile, Kevin P.
Lovell, Scott
Harry Nhat Nguyen
Lushington, Gerald H.
Chang, Kyeong-Ok
Groutas, William C.
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 143 : 881 - 890
[5] Oxadiazole-based cell permeable macrocyclic transition state inhibitors of norovirus 3CL protease
Damalanka, Vishnu
Kim, Yunjeong
Alliston, Kevin
Weerawarna, Pathum
Kankanamalage, Anushka Galasiti
Lushington, Gerald
Mehzabeen, Nurjahan
Kevin, Battaile
Lovell, Scott
Chang, Kyeong-Ok
Groutas, William
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
[6] Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease
Damalanka, Vishnu C.
Kim, Yunjeong
Alliston, Kevin R.
Weerawarna, Pathum M.
Kankanamalage, Anushka C. Galasiti
Lushington, Gerald H.
Mehzabeen, Nurjahan
Battaile, Kevin P.
Lovell, Scott
Chang, Kyeong-Ok
Groutas, William C.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (05) : 1899 - 1913
[7] Structure-based design and optimization of dipeptidyl inhibitors of norovirus 3CL protease
Kankanamalage, Anushka C. Galasiti
Weerawarna, Pathum M.
Uy, Roxanne Adeline Z.
Mandadapu, Sivakoteswara Rao
Alliston, Kevin R.
Chang, Kyeong-Ok
Kim, Yunjeong
Lovell, Scott
Hua, Duy H.
Prior, Allan M.
Groutas, Willam C.
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
[8] Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease
Shao, Yi-Ming
Yang, Wen-Bin
Kuo, Tun-Hsun
Tsai, Keng-Chang
Lin, Chun-Hung
Yang, An-Suei
Liang, Po-Huang
Wong, Chi-Huey
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (08) : 4652 - 4660
[9] Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease
Konno, Hiroyuki
Wakabayashi, Masaki
Takanuma, Daiki
Saito, Yota
Akaji, Kenichi
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (06) : 1241 - 1254
[10] Inhibition of norovirus 3CL protease by bisulfite adducts of transition state inhibitors
Mandadapu, Sivakoteswara Rao
Gunnam, Mallikarjuna Reddy
Tiew, Kok-Chuan
Uy, Roxanne Adeline Z.
Prior, Allan M.
Alliston, Kevin R.
Hua, Duy H.
Kim, Yunjeong
Chang, Kyeong-Ok
Groutas, William C.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (01) : 62 - 65

← 1 2 3 4 5 →